Bausch + Lomb (BLCO) News Today $15.18 -0.01 (-0.06%) As of 02:46 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock BLCO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period Brokerages Set Bausch + Lomb Corporation (NYSE:BLCO) PT at $15.56September 15 at 2:21 AM | americanbankingnews.comDynamic Technology Lab Private Ltd Sells 23,145 Shares of Bausch + Lomb Corporation $BLCOSeptember 14 at 3:45 AM | marketbeat.comBausch + Lomb Corporation (NYSE:BLCO) Given Consensus Recommendation of "Hold" by BrokeragesSeptember 14 at 2:44 AM | marketbeat.comBausch + Lomb (NYSE:BLCO) vs. PACS Group (NYSE:PACS) Critical ReviewSeptember 12 at 3:59 AM | americanbankingnews.comVident Advisory LLC Invests $289,000 in Bausch + Lomb Corporation $BLCOSeptember 12 at 3:22 AM | marketbeat.comBausch + Lomb publishes enVista Envy trial resultsSeptember 11, 2025 | msn.comBausch + Lomb (BLCO) Study Shows XIIDRA Eye Drops Improve Comfort For Contact Lens WearersSeptember 11, 2025 | finance.yahoo.comClearline Capital LP Purchases 247,149 Shares of Bausch + Lomb Corporation $BLCOSeptember 10, 2025 | marketbeat.comBausch + Lomb Announces Publication of Data From a Prospective Study Evaluating the Efficacy of XIIDRA® in Alleviating Discomfort in Symptomatic Contact Lens WearersSeptember 9, 2025 | finance.yahoo.comBausch + Lomb (BLCO) Stock Trades Up, Here Is WhySeptember 9, 2025 | msn.comBausch + Lomb’s XIIDRA Shows Promising Results for Contact Lens WearersSeptember 9, 2025 | tipranks.comCubist Systematic Strategies LLC Purchases New Shares in Bausch + Lomb Corporation $BLCOSeptember 9, 2025 | marketbeat.comBausch + Lomb Corporation (BLCO) Bausch + Lomb Corporation Presents At Morgan Stanley 23rd Annual Global Healthcare Conference (Transcript)September 8, 2025 | seekingalpha.comBausch + Lomb Expands Specialty Vision Portfolio with ASANA Lens LaunchSeptember 8, 2025 | msn.comBausch + Lomb Launches ASANA™ Gas Permeable Lenses in the United StatesSeptember 8, 2025 | finance.yahoo.comNexpoint Asset Management L.P. Has $727,000 Holdings in Bausch + Lomb Corporation $BLCOSeptember 7, 2025 | marketbeat.comMagnetar Financial LLC Acquires Shares of 27,063 Bausch + Lomb Corporation $BLCOSeptember 4, 2025 | marketbeat.comAlpine Global Management LLC Boosts Stake in Bausch + Lomb Corporation $BLCOSeptember 2, 2025 | marketbeat.com100,000 Shares in Bausch + Lomb Corporation $BLCO Bought by Landscape Capital Management L.L.C.September 1, 2025 | marketbeat.comBausch + Lomb (BLCO) Stock Is Up, What You Need To KnowAugust 22, 2025 | msn.comWhy BHC, BLCO, and Pepsi are Under the RadarAugust 20, 2025 | baystreet.caBausch + Lomb announces Brett Icahn, Gary Hu resign from boardAugust 19, 2025 | msn.comBausch + Lomb Corporation (NYSE:BLCO) Given Consensus Rating of "Hold" by AnalystsAugust 19, 2025 | marketbeat.comBausch + Lomb Ends Agreement with Icahn GroupAugust 18, 2025 | tipranks.comBausch + Lomb Announces Board ChangesAugust 18, 2025 | businesswire.comBausch + Lomb (NYSE:BLCO) Shares Up 5.1% - Here's What HappenedAugust 17, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Upgraded at Zacks ResearchAugust 17, 2025 | marketbeat.comBausch Health rises after $300M worth insider purchase (update)August 15, 2025 | msn.com1 Safe-and-Steady Stock with Competitive Advantages and 2 That UnderwhelmAugust 15, 2025 | finance.yahoo.comBausch + Lomb to Engage in Key September Investor ConferencesAugust 14, 2025 | msn.comBausch + Lomb to Participate in Upcoming Investor ConferencesAugust 14, 2025 | businesswire.comBLCO Q2 Deep Dive: Product Launches Offset Margin Pressures, Management Highlights Pipeline InvestmentsAugust 13, 2025 | uk.finance.yahoo.comDeutsche Bank AG Takes $50.75 Million Position in Bausch + Lomb Corporation (NYSE:BLCO)August 13, 2025 | marketbeat.com1 Stock Under $50 to Target This Week and 2 We IgnoreAugust 7, 2025 | finance.yahoo.comTD Asset Management Inc Purchases Shares of 40,578 Bausch + Lomb Corporation (NYSE:BLCO)August 5, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, Morgan Stanley Analyst SaysAugust 2, 2025 | marketbeat.comBausch + Lomb Corporation (NYSE:BLCO) Shares Bought by Alberta Investment Management CorpAugust 2, 2025 | marketbeat.comBausch + Lomb (NYSE:BLCO) Stock Price Expected to Rise, HC Wainwright Analyst SaysAugust 1, 2025 | marketbeat.comWells Fargo & Company Forecasts Strong Price Appreciation for Bausch + Lomb (NYSE:BLCO) StockAugust 1, 2025 | marketbeat.comBausch & Lomb Corp (TSX:BLCO) Q2 2025: Everything You Need To Know Ahead Of EarningsJuly 31, 2025 | finance.yahoo.comBausch + Lomb’s Earnings Call: Growth Amid ChallengesJuly 31, 2025 | tipranks.comWhy Bausch + Lomb (BLCO) Stock Is Down TodayJuly 31, 2025 | msn.comBausch Lomb (BLCO) Q2 Revenue Rises 5%July 30, 2025 | fool.comBausch + Lomb Corporation (BLCO) Q2 2025 Earnings Call TranscriptJuly 30, 2025 | seekingalpha.comBausch + Lomb Corporation 2025 Q2 - Results - Earnings Call PresentationJuly 30, 2025 | seekingalpha.comExamining the Future: Bausch & Lomb's Earnings OutlookJuly 30, 2025 | benzinga.comBausch + Lomb tops Q2 expectations, raises full-year guidanceJuly 30, 2025 | investing.comBausch + Lomb’s (NYSE:BLCO) Q2 Sales Top Estimates, Full-Year Outlook Slightly Exceeds ExpectationsJuly 30, 2025 | finance.yahoo.comBausch + Lomb Reports Q2 2025 Revenue Growth, Raises Full-Year GuidanceJuly 30, 2025 | tipranks.comBausch + Lomb Announces Second-Quarter 2025 ResultsJuly 30, 2025 | businesswire.com Get Bausch + Lomb News Delivered to You Automatically Sign up to receive the latest news and ratings for BLCO and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BLCO Media Mentions By Week BLCO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BLCO News Sentiment▼0.660.94▲Average Medical News Sentiment BLCO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BLCO Articles This Week▼146▲BLCO Articles Average Week Get the Latest News and Ratings for BLCO and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Bausch + Lomb and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Zimmer Biomet News Today Smith & Nephew SNATS News Today Solventum News Today Penumbra News Today Stevanato Group News Today iRhythm Technologies News Today Glaukos News Today Soleno Therapeutics News Today TransMedics Group News Today Envista News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:BLCO) was last updated on 9/15/2025 by MarketBeat.com Staff From Our PartnersOut of 18,347 Cryptocurrencies... This is the ONLY OneThe Single Most Undervalued DeFi Protocol You've Never Heard Of If there's one cryptocurrency you should b...Crypto 101 Media | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredWhy Trump’s “Smart Dollar” could rewrite the rulesMUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's lates...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredForget AI Stocks — This Device Will REPLACE the MicrochipWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Bausch + Lomb Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Bausch + Lomb With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
